Research On The Integration Effect Of Mergers And Acquisitions Of Fosun Pharma

In recent years,with the continuous improvement of per capita income and the improvement of people's health concept brought by China's economic development,the scale of China's pharmaceutical market has expanded rapidly.However,the volume of Chinese pharmaceutical industry is not large enough,the industry concentration is low,and the scale effect is not obvious;and the innovative ability of new drug research and development is not strong,and the configuration structure of high-end and low-end products is unreasonable.With China's growth into the world's largest emerging pharmaceutical market and the opening of China's pharmaceutical market,foreign pharmaceutical giants who have experienced the baptism of mature pharmaceutical market have gradually entered the Chinese pharmaceutical market,and the competition in the domestic pharmaceutical industry has become increasingly fierce.Chinese pharmaceutical enterprises are not strong in research and development ability and lack of core competitiveness,and most of them can only rely on the closed protection of the domestic pharmaceutical market.Low-level competition and other issues are gradually exposed,and the challenges faced by domestic pharmaceutical enterprises are becoming more and more serious,especially the increasing demand for research and development capabilities of pharmaceutical enterprises.Compared with endogenous research and development,mergers and acquisitions can rapidly improve the innovation ability of enterprises,but the number of target enterprises with core technology in many pharmaceutical enterprises in China is very small.Therefore,domestic pharmaceutical companies have made overseas mergers and acquisitions in succession,hoping to obtain patents and technology quickly through mergers and acquisitions;even integrate the mergers and acquisitions innovation ability of foreign mergers and acquisitions target companies,management experience and sales network,and improve products structure and industrial chain,so as to enhance the level of profits and expand the strength of the company.With the frequent occurrence of overseas mergers and acquisitions of pharmaceutical enterprises,whether overseas mergers and acquisitions can improve enterprise performance has attracted more and more attention.Fosun Pharma,as the PE of the pharmaceutical industry,relies on active mergers and acquisitions measures to successfully achieve technology acquisition,scale leap and company strength expansion.The reasons behind this phenomenon are worth summarizing.This paper reviews and summarizes the research on the motivation and effect of mergers and acquisitions.According to the logical thinking of "using mergers and acquisitions motivation mergers and acquisitions results",it summarizes the mergers and acquisitions activities and characteristics of Fosun Pharma since 2004,and summarizes the mergers and acquisitions motivation and target company of Fosun Pharma Series.Select the principles and integration methods after mergers and acquisitions,and take Fosun Pharma's mergers and acquisitions of Gland Pharma Company of India as an example,combined with the existing research results,summarize the motivation of Fosun Pharma's mergers and acquisitions.Based on the financial indicators,the synergistic effect of mergers and acquisitions of Fosun Pharma was evaluated,and the successful experience and possible problems of mergers and acquisitions of Chinese pharmaceutical enterprises represented by Fosun Pharma were summarized.Finally,some suggestions are put forward in order to provide enlightenment and ideas for the mergers and acquisitions,expansion and development of Chinese pharmaceutical enterprises.